MeSH term | MeSH ID | Detail |
---|---|---|
Cholecystitis, Acute | D041881 | 1 associated lipids |
Gastric Dilatation | D013271 | 1 associated lipids |
Stomach Volvulus | D013277 | 1 associated lipids |
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Henriksson P et al. | In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction. | 1986 | Br Heart J | pmid:3521690 |
Adatia I et al. | Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease. | 1993 | Br Heart J | pmid:8435245 |
Adatia I et al. | Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt. | 1994 | Br Heart J | pmid:7818962 |
Rasmanis G et al. | Evidence of increased platelet activation after thrombolysis in patients with acute myocardial infarction. | 1992 | Br Heart J | pmid:1449919 |
Neiman J | Association of transient ischaemic attack in alcohol withdrawal with changes in haemostasis. | 1988 | Br J Addict | pmid:3233412 |
Barbara J et al. | Prevention of latex sensitization in guinea pigs by a bacterial and viral filter used in anaesthesia. | 2005 | Br J Anaesth | pmid:15980041 |
Khazam A et al. | Enhanced thromboxane synthesis with extradural anaesthesia. | 1990 | Br J Anaesth | pmid:2317426 |
Munsterhjelm E et al. | Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers. | 2006 | Br J Anaesth | pmid:16698862 |
Schweizer A et al. | Aprotinin does not impair renal haemodynamics and function after cardiac surgery. | 2000 | Br J Anaesth | pmid:10740541 |
Bellamy MC et al. | Changes in inflammatory mediators during orthotopic liver transplantation. | 1997 | Br J Anaesth | pmid:9389852 |
Schilling MK et al. | Role of thromboxane and leukotriene B4 in patients with acute respiratory distress syndrome after oesophagectomy. | 1998 | Br J Anaesth | pmid:9505775 |
Oelkers R et al. | Disposition and effects of flurbiprofen enantiomers in human serum and blister fluid. | 1997 | Br J Clin Pharmacol | pmid:9131946 |
Kirchheiner J et al. | Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans. | 2003 | Br J Clin Pharmacol | pmid:12534640 |
Hayball PJ et al. | The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis. | 1993 | Br J Clin Pharmacol | pmid:9114902 |
Rosenkranz B et al. | Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. | 1986 | Br J Clin Pharmacol | pmid:3083851 |
Salvetti A et al. | The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients. | 1984 | Br J Clin Pharmacol | pmid:6378233 |
Ferry N et al. | Influence of renal insufficiency on the pharmacokinetics of cicletanine and its effects on the urinary excretion of electrolytes and prostanoids. | 1988 | Br J Clin Pharmacol | pmid:3358898 |
Nieminen MM et al. | Inhaled budesonide fails to inhibit the PAF-induced increase in plasma leukotriene B4 in man. | 1992 | Br J Clin Pharmacol | pmid:1327049 |
Harlan J et al. | Selective inhibition of thromboxane synthesis during experimental endotoxemia in the goat: effects on pulmonary haemodynamics and lung lymph flow. | 1983 | Br J Clin Pharmacol | pmid:6337602 |
Ball HA et al. | Effect of dazoxiben, a specific inhibitor of thromboxane synthetase, on acute pulmonary responses to E. coli endotoxin in anaesthetized cats. | 1983 | Br J Clin Pharmacol | pmid:6337603 |
Dodd NJ et al. | Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis. | 1983 | Br J Clin Pharmacol | pmid:6337605 |
Pallapies D et al. | Effects on platelet functions and pharmacokinetics of azapropazone and ketorolac tromethamine given as single parenteral doses. | 1994 | Br J Clin Pharmacol | pmid:8018454 |
Parry MJ | Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour. | 1983 | Br J Clin Pharmacol | pmid:6401997 |
Kiff PS et al. | Haemodynamic and metabolic effects of dazoxiben at rest and during atrial pacing. | 1983 | Br J Clin Pharmacol | pmid:6681708 |
Hutton I et al. | Effects of dazoxiben on transcardiac thromboxane levels and haemodynamics in coronary heart disease. | 1983 | Br J Clin Pharmacol | pmid:6681709 |
Hawthorne AB et al. | Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. | 1991 | Br J Clin Pharmacol | pmid:1888645 |
Randall MJ and Wilding RI | Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01). | 1983 | Br J Clin Pharmacol | pmid:6687429 |
Shephard EG et al. | Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F1 alpha and beta-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment. | 1985 | Br J Clin Pharmacol | pmid:2581599 |
Wallén NH et al. | Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris. | 1994 | Br J Clin Pharmacol | pmid:7946939 |
Villanueva M et al. | Equipotent inhibition by R(-)-, S(+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro. | 1993 | Br J Clin Pharmacol | pmid:8385973 |
Barrow SE et al. | Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease. | 1991 | Br J Clin Pharmacol | pmid:1909541 |
van Kraaij DJ et al. | A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers. | 2002 | Br J Clin Pharmacol | pmid:12047490 |
Brown N et al. | Comparison of antiplatelet activity of microencapsulated aspirin 162.5 Mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis. | 1999 | Br J Clin Pharmacol | pmid:10383561 |
Reuben SR et al. | Effects of dazoxiben on exercise performance in chronic stable angina. | 1983 | Br J Clin Pharmacol | pmid:6402000 |
Floyd CN et al. | Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. | 2014 | Br J Clin Pharmacol | pmid:25099258 |
Ritter JM et al. | Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man. | 1989 | Br J Clin Pharmacol | pmid:2590611 |
Shinkai Y and Cameron JS | Trial of platelet-derived growth factor antagonist, trapidil, in accelerated nephrotoxic nephritis in the rabbit. | 1987 | Br J Exp Pathol | pmid:3480754 |
Tissot M et al. | Prostanoid release by macrophages at a distance from an inflammatory site. | 1989 | Br J Exp Pathol | pmid:2818931 |
Rousselle MA et al. | Effect of alkali treatment on physiological activity of cotton condensed tannin. | 1990 | Br J Ind Med | pmid:2223662 |
Mitchell MD et al. | Thromboxane B2 in amniotic fluid before and during labour. | 1978 | Br J Obstet Gynaecol | pmid:656348 |
Roy AC et al. | Thromboxane A2 and prostacyclin levels in molar pregnancy. | 1984 | Br J Obstet Gynaecol | pmid:6383461 |
Smith AJ et al. | Hypertensive and normal pregnancy: a longitudinal study of blood pressure, distensibility of dorsal hand veins and the ratio of the stable metabolites of thromboxane A2 and prostacyclin in plasma. | 1995 | Br J Obstet Gynaecol | pmid:8534627 |
Ylikorkala O et al. | Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2. | 1983 | Br J Obstet Gynaecol | pmid:6338904 |
Louden KA et al. | Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin. | 1994 | Br J Obstet Gynaecol | pmid:8193093 |
Greer IA et al. | Immunoreactive prostacyclin and thromboxane metabolites in normal pregnancy and the puerperium. | 1985 | Br J Obstet Gynaecol | pmid:3890936 |
Benedetto C et al. | Production of prostacyclin, 6-keto-PGF1 alpha and thromboxane B2 by human umbilical vessels increases from the placenta towards the fetus. | 1987 | Br J Obstet Gynaecol | pmid:3322374 |
Kilby MD | Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin and platelet activation in normotensive and hypertensive pregnancies complicated by intrauterine growth retardation. | 1994 | Br J Obstet Gynaecol | pmid:7864999 |
McCowan LM et al. | Administration of low-dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birthweight: a randomised double-blind controlled trial. | 1999 | Br J Obstet Gynaecol | pmid:10428519 |
Louden KA et al. | Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. | 1991 | Br J Obstet Gynaecol | pmid:1777456 |
Ahmed Y et al. | Increased platelet turnover in a patient with previous recurrent pre-eclampsia and failure of aspirin therapy. Case report. | 1991 | Br J Obstet Gynaecol | pmid:2004060 |
Kohout M et al. | Cool perfusion solutions for skin flaps: a new mixture of pharmacological agents which improves skin flap viability. | 1995 | Br J Plast Surg | pmid:7735675 |
Murphy RC et al. | Surgical delay and arachidonic acid metabolites: evidence for an inflammatory mechanism: an experimental study in rats. | 1985 | Br J Plast Surg | pmid:3921087 |
Blann AD et al. | Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery disease. | 2001 | Br J Radiol | pmid:11560828 |
Barry MC et al. | Immunological and physiological responses to aortic surgery: effect of reperfusion on neutrophil and monocyte activation and pulmonary function. | 1997 | Br J Surg | pmid:9112905 |
Fletcher MS et al. | Endotoxin, prostaglandins and renal fibrin deposition in obstructive jaundice. | 1982 | Br J Surg | pmid:6751458 |
Webb PJ et al. | Do prostacyclin and thromboxane play a role in endotoxic shock? | 1981 | Br J Surg | pmid:7025959 |
Wilkinson D et al. | Plasma eicosanoids, platelet function and cold sensitivity. | 1989 | Br J Surg | pmid:2720355 |
Edwards AT et al. | Systemic responses in patients with intermittent claudication after treadmill exercise. | 1994 | Br J Surg | pmid:7827927 |
Yamaga H et al. | Platelet aggregability after endoscopic intravariceal injection of 5 per cent ethanolamine oleate into oesophageal varices. | 1989 | Br J Surg | pmid:2804591 |
Horgan PG et al. | Extracorporeal shock wave lithotripsy induces the release of prostaglandins which increase ureteric peristalsis. | 1993 | Br J Urol | pmid:8343888 |
Zwergel U et al. | Eicosanoid synthesis in the isolated human renal pelvis, ureter and bladder. | 1991 | Br J Urol | pmid:2021808 |
Ylikorkala O and Viinikka L | Thromboxane A2 in pregnancy and puerperium. | 1980 | Br Med J | pmid:7448530 |
Reilly IA et al. | Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. | 1986 | Br Med J (Clin Res Ed) | pmid:3083991 |
Mikhailidis DP et al. | Platelet function defects in chronic alcoholism. | 1986 | Br Med J (Clin Res Ed) | pmid:3094624 |
Ylikorkala O et al. | Prostacyclin and thromboxane in diabetes. | 1981 | Br Med J (Clin Res Ed) | pmid:6794795 |
Lee SH et al. | Prostacyclin and thromboxane A2 in thrombotic thrombocytopenic purpura. | 1981 | Br Med J (Clin Res Ed) | pmid:6797537 |
Bennett A et al. | Cancer in mice: effects of prednisolone or mepacrine alone and with cytotoxic drugs. | 1987 | Br. J. Cancer | pmid:3580263 |
Aitokallio-Tallberg A et al. | Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment. | 1989 | Br. J. Cancer | pmid:2803956 |
Laekeman GM et al. | Prostacyclin and thromboxane in benign and malignant breast tumours. | 1986 | Br. J. Cancer | pmid:3530307 |
Aitokallio-Tallberg A et al. | Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate. | 1985 | Br. J. Cancer | pmid:2986666 |
Stamford IF et al. | Survival of mice with NC carcinoma is unchanged by drugs that are thought to inhibit thromboxane synthesis or increase prostacyclin formation. | 1986 | Br. J. Cancer | pmid:3755610 |
Karmali RA et al. | Prostaglandins in breast cancer: relationship to disease stage and hormone status. | 1983 | Br. J. Cancer | pmid:6416285 |
Izaki S et al. | Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation. | 1996 | Br. J. Dermatol. | pmid:8763425 |
Schalin-Karrila M et al. | Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins. | 1987 | Br. J. Dermatol. | pmid:3307886 |
Maurice PD et al. | The effects of dietary supplementation with fish oil in patients with psoriasis. | 1987 | Br. J. Dermatol. | pmid:3689678 |
Tobelem G et al. | Further studies on a specific platelet antibody found in Bernard-Soulier syndrome and its effects on normal platelet function. | 1979 | Br. J. Haematol. | pmid:427045 |
Ford I et al. | Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. | 1993 | Br. J. Haematol. | pmid:8338784 |
Yardumian DA et al. | Platelet hyperaggregability occurring during prolonged continuous intravenous infusions of prostacyclin analogue ZK 36374. | 1985 | Br. J. Haematol. | pmid:2408653 |
Cartwright IJ et al. | A haemorrhagic platelet disorder associated with altered stimulus-response coupling and abnormal membrane phospholipid composition. | 1994 | Br. J. Haematol. | pmid:7803235 |
Martinuzzo ME et al. | Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies. | 2001 | Br. J. Haematol. | pmid:11564073 |
Russell NH et al. | Thrombocytopathy in preleukaemia: association with a defect of thromboxane A2 activity. | 1979 | Br. J. Haematol. | pmid:570847 |
Sheu JR et al. | Mechanisms involved in the antiplatelet activity of magnesium in human platelets. | 2002 | Br. J. Haematol. | pmid:12472585 |
Kurantsin-Mills J et al. | Elevated urinary levels of thromboxane and prostacyclin metabolities in sickle cell disease reflects activated platelets in the circulation. | 1994 | Br. J. Haematol. | pmid:7993800 |
Borowska A et al. | Impairment of primary haemostasis by low molecular weight heparins in rats. | 1988 | Br. J. Haematol. | pmid:3355792 |
Walker ID et al. | A double blind study of prostacyclin in cardiopulmonary bypass surgery. | 1981 | Br. J. Haematol. | pmid:6457624 |
Eldor A et al. | A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. | 1999 | Br. J. Haematol. | pmid:10606878 |
Worthington RE et al. | Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor. | 1990 | Br. J. Haematol. | pmid:2317457 |
Jakubowski JA et al. | Cumulative antiplatelet effect of low-dose enteric coated aspirin. | 1985 | Br. J. Haematol. | pmid:3927970 |
Jakubowski JA et al. | Arachidonic acid metabolism by platelets of differing size. | 1983 | Br. J. Haematol. | pmid:6402003 |
Lagarde M et al. | Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase. | 1978 | Br. J. Haematol. | pmid:205238 |
Hardisty RM et al. | A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium. | 1983 | Br. J. Haematol. | pmid:6830700 |
Kaaja R et al. | Increased thromboxane production in women with a history of venous thromboembolic event: effect of heparins. | 2001 | Br. J. Haematol. | pmid:11552994 |
Dubé JN et al. | Characterization of a partial prostaglandin endoperoxide H synthase-1 deficiency in a patient with a bleeding disorder. | 2001 | Br. J. Haematol. | pmid:11442478 |
Pan IQ et al. | Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives. | 1984 | Br. J. Haematol. | pmid:6089860 |
Wang L et al. | Enhancement of human platelet activation by the combination of low concentrations of collagen and rabbit anticardiolipin antibodies. | 2002 | Br. J. Haematol. | pmid:12199800 |
Altieri DC et al. | von Willebrand factor contaminating porcine factor VIII concentrate (Hyate:C) causes platelet aggregation. | 1986 | Br. J. Haematol. | pmid:2942172 |
Faint RW et al. | Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro. | 1991 | Br. J. Haematol. | pmid:1851034 |
Faili A et al. | Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation. | 1994 | Br. J. Haematol. | pmid:7803237 |
Rousson D et al. | Increased in vivo biosynthesis of prostacyclin and thromboxane A2 in chronic idiopathic thrombocytopenic purpura. | 1989 | Br. J. Haematol. | pmid:2669929 |
Henry A et al. | Inhibition of platelet activation by the Alzheimer's disease amyloid precursor protein. | 1998 | Br. J. Haematol. | pmid:9827912 |